Better Economy, Growing Cash Positions Point to M&A Recovery for Life Science Tools Firms

Industry experts said that further consolidation in the field and a continued strategy by companies to diversify their end markets should translate to more deals in the year ahead.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories